#5 Lipid Lowering Agents And Myopathy | Cardiology, Pharmacology | MedFlashGo Question Of The Day

#5 Lipid Lowering Agents And Myopathy | Cardi...

Up next

#230 Urinary incontinence types | Ob/gyn | Clinical | MedFlashGo Question of the Day For Medical Students | USMLE, COMLEX, Medical Boards, Shelf

Welcome To The MedFlashGo Podcast. This Is Your Daily 4 Minutes Or Less Rapid Review for medical students. Topics are based on medical board examinations including USMLE, COMLEX, And Shelf Exams. We release a new episode every weekday! In this question of the day, Sean asks stude ...  Show more

#229 Acute DVT/PE treatment | Pharmacology | Emergency Medicine | MedFlashGo Question of the Day For Medical Students | USMLE, COMLEX, Medical Boards, Shelf

Welcome To The MedFlashGo Podcast. This Is Your Daily 4 Minutes Or Less Rapid Review for medical students. Topics are based on medical board examinations including USMLE, COMLEX, And Shelf Exams. We release a new episode every weekday! In this question of the day, Sean asks stude ...  Show more

Recommended Episodes

236. CP Examination Pharmacology
The NPTE Podcast

During examination, a patient's chart indicates that they have been prescribed lisinopril (Prinivil). Which of the following primary effects is this medication MOST likely to elicit? Find it all out in the podcast! Be prepared for the NPTE so that you can pass with flying colors! ...  Show more

Is Pharmacology Difficult Podcast ANTICHOLINERGIC DRUGS-REVISION/SUMMARY
IS PHARMACOLOGY DIFFICULT®️ Podcast

Welcome all to IS PHARMACOLOGY DIFFICULT Podcast! I am Dr Radhika Vijay.In this episode, I will be doing a RAPID FIRE Question-Answer Round of around 15-17 questions about ANTICHOLINERGIC DRUGS, a sort of Quick Revision or Summary we can say. I am sure this will be a great closin ...  Show more

Lipid Drugs: Part 1
Mayo Clinic Cardiovascular CME

Lipid Drugs: Part 1

 

Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N

Host: Stephen L. Kopecky, M.D.

 

In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available ...

  Show more